Participation of NK1 receptors in nociceptin-induced modulation of rat knee joint mechanosensitivity.
Nociceptin is known to act peripherally in the rat knee joint to modulate articular mechanosensitivity and it has been postulated that neurokinin-1 (NK1) receptors may be involved in this process. To test this hypothesis, single unit extracellular recordings were made from knee joint primary afferents in response to normal and extreme rotation of the joint. Afferent firing rate was assessed following close intraarterial injection of the NK1 antagonist RP67580 followed by administration of 20 nmol nociceptin. With both normal and hyper-rotation of the knee, nociceptin was unable to elicit its usual mechanomodulatory effect such that afferent activity was not significantly different from control (P = 0.7572 and P = 0.9182 for normal and hyper-rotation of the joint, respectively). These data indicate that nociceptin-induced mechanosensitivity changes in the rat knee depend upon NK1 receptor activation possibly through secondary release of substance P.
McDougall
J J
JJ
McCaig Centre for Joint Injury and Arthritis Research, 3330, Hospital Drive NW, University of Calgary, Calgary, AB., T2 N 4N1, Canada. mcdougaj@ucalgary.ca
Hanesch
U
U
Pawlak
M
M
Schmidt
R F
RF
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000344:Afferent Pathways / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D007211:Indoles / Q000494:pharmacology; D054833:Isoindoles; D007719:Knee Joint / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism; D008297:Male; D008465:Mechanoreceptors / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D064729:Neurokinin-1 Receptor Antagonists; D009475:Neurons, Afferent / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D018847:Opioid Peptides / Q000378:metabolism / Q000494:pharmacology*; D010812:Physical Stimulation; D011434:Proprioception / Q000187:drug effects / Q000502:physiology*; D016059:Range of Motion, Articular / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D018040:Receptors, Neurokinin-1 / Q000819:agonists / Q000378:metabolism*; D013373:Substance P / Q000494:pharmacology; D000097629:Nociceptin
D000700:Analgesics; D007211:Indoles; D054833:Isoindoles; D064729:Neurokinin-1 Receptor Antagonists; D018847:Opioid Peptides; D018040:Receptors, Neurokinin-1; D013373:Substance P; D000097629:Nociceptin; C071693:7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one